BindingDB logo
myBDB logout

null

SMILES: CCOC(=O)N[C@@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1

InChI Key: InChIKey=BYJLEOXPONSXOY-HDICACEKSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 50207110   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
5-hydroxytryptamine receptor 2A


(Homo sapiens (Human))
BDBM50207110
PNG
(CHEMBL3923240 | US9550741, III-15)
Show SMILES CCOC(=O)N[C@@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1 |r,wU:9.9,6.5,(54.47,-17.58,;52.93,-17.65,;52.1,-16.36,;50.55,-16.44,;49.86,-17.82,;49.78,-15.11,;48.24,-15.11,;47.47,-13.77,;45.93,-13.77,;45.16,-15.11,;43.62,-15.11,;42.85,-13.77,;41.31,-13.77,;40.54,-15.11,;39,-15.11,;38.23,-13.77,;39,-12.44,;40.54,-12.44,;36.69,-13.77,;35.79,-15.02,;34.32,-14.54,;34.32,-13,;33.18,-11.98,;33.5,-10.47,;34.97,-9.99,;36.11,-11.02,;35.79,-12.53,;45.93,-16.44,;47.47,-16.44,)|
Show InChI InChI=1S/C22H32N4O2S/c1-2-28-22(27)23-18-9-7-17(8-10-18)11-12-25-13-15-26(16-14-25)21-19-5-3-4-6-20(19)29-24-21/h3-6,17-18H,2,7-16H2,1H3,(H,23,27)/t17-,18+
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
0.180n/an/an/an/an/an/an/an/a



Shanghai Jiao Tong University

Curated by ChEMBL


Assay Description
Displacement of [3H]ketanserin from recombinant human 5-HT2A receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting meth...


Eur J Med Chem 123: 332-353 (2016)


Article DOI: 10.1016/j.ejmech.2016.07.038
BindingDB Entry DOI: 10.7270/Q2GH9KXP
More data for this
Ligand-Target Pair
Vitamin D3 receptor


(Homo sapiens (Human))
BDBM50207110
PNG
(CHEMBL3923240 | US9550741, III-15)
Show SMILES CCOC(=O)N[C@@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1 |r,wU:9.9,6.5,(54.47,-17.58,;52.93,-17.65,;52.1,-16.36,;50.55,-16.44,;49.86,-17.82,;49.78,-15.11,;48.24,-15.11,;47.47,-13.77,;45.93,-13.77,;45.16,-15.11,;43.62,-15.11,;42.85,-13.77,;41.31,-13.77,;40.54,-15.11,;39,-15.11,;38.23,-13.77,;39,-12.44,;40.54,-12.44,;36.69,-13.77,;35.79,-15.02,;34.32,-14.54,;34.32,-13,;33.18,-11.98,;33.5,-10.47,;34.97,-9.99,;36.11,-11.02,;35.79,-12.53,;45.93,-16.44,;47.47,-16.44,)|
Show InChI InChI=1S/C22H32N4O2S/c1-2-28-22(27)23-18-9-7-17(8-10-18)11-12-25-13-15-26(16-14-25)21-19-5-3-4-6-20(19)29-24-21/h3-6,17-18H,2,7-16H2,1H3,(H,23,27)/t17-,18+
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

US Patent
0.460n/an/an/an/an/an/an/an/a



Shanghai Institute of Pharmaceutical Industry

US Patent


Assay Description
The experiment is carried out by the method according to Journal of Pharmacology and Experimental Therapeutics 2010, 333(1): 328. With [3H]methyl-spi...


US Patent US9550741 (2017)


BindingDB Entry DOI: 10.7270/Q2DN4726
More data for this
Ligand-Target Pair
Vitamin D3 receptor


(Homo sapiens (Human))
BDBM50207110
PNG
(CHEMBL3923240 | US9550741, III-15)
Show SMILES CCOC(=O)N[C@@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1 |r,wU:9.9,6.5,(54.47,-17.58,;52.93,-17.65,;52.1,-16.36,;50.55,-16.44,;49.86,-17.82,;49.78,-15.11,;48.24,-15.11,;47.47,-13.77,;45.93,-13.77,;45.16,-15.11,;43.62,-15.11,;42.85,-13.77,;41.31,-13.77,;40.54,-15.11,;39,-15.11,;38.23,-13.77,;39,-12.44,;40.54,-12.44,;36.69,-13.77,;35.79,-15.02,;34.32,-14.54,;34.32,-13,;33.18,-11.98,;33.5,-10.47,;34.97,-9.99,;36.11,-11.02,;35.79,-12.53,;45.93,-16.44,;47.47,-16.44,)|
Show InChI InChI=1S/C22H32N4O2S/c1-2-28-22(27)23-18-9-7-17(8-10-18)11-12-25-13-15-26(16-14-25)21-19-5-3-4-6-20(19)29-24-21/h3-6,17-18H,2,7-16H2,1H3,(H,23,27)/t17-,18+
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

US Patent
0.460n/an/an/an/an/an/an/an/a



Shanghai Institute of Pharmaceutical Industry

US Patent


Assay Description
The experiment is carried out by the method according to Journal of Pharmacology and Experimental Therapeutics 2010, 333(1): 328. With [3H]methyl-spi...


US Patent US9550741 (2017)


BindingDB Entry DOI: 10.7270/Q2DN4726
More data for this
Ligand-Target Pair
5-hydroxytryptamine receptor 1A


(Homo sapiens (Human))
BDBM50207110
PNG
(CHEMBL3923240 | US9550741, III-15)
Show SMILES CCOC(=O)N[C@@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1 |r,wU:9.9,6.5,(54.47,-17.58,;52.93,-17.65,;52.1,-16.36,;50.55,-16.44,;49.86,-17.82,;49.78,-15.11,;48.24,-15.11,;47.47,-13.77,;45.93,-13.77,;45.16,-15.11,;43.62,-15.11,;42.85,-13.77,;41.31,-13.77,;40.54,-15.11,;39,-15.11,;38.23,-13.77,;39,-12.44,;40.54,-12.44,;36.69,-13.77,;35.79,-15.02,;34.32,-14.54,;34.32,-13,;33.18,-11.98,;33.5,-10.47,;34.97,-9.99,;36.11,-11.02,;35.79,-12.53,;45.93,-16.44,;47.47,-16.44,)|
Show InChI InChI=1S/C22H32N4O2S/c1-2-28-22(27)23-18-9-7-17(8-10-18)11-12-25-13-15-26(16-14-25)21-19-5-3-4-6-20(19)29-24-21/h3-6,17-18H,2,7-16H2,1H3,(H,23,27)/t17-,18+
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
0.570n/an/an/an/an/an/an/an/a



Shanghai Jiao Tong University

Curated by ChEMBL


Assay Description
Displacement of [3H]8-OH-DPAT from recombinant human 5-HT1A receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting metho...


Eur J Med Chem 123: 332-353 (2016)


Article DOI: 10.1016/j.ejmech.2016.07.038
BindingDB Entry DOI: 10.7270/Q2GH9KXP
More data for this
Ligand-Target Pair
5-hydroxytryptamine receptor 2A


(Homo sapiens (Human))
BDBM50207110
PNG
(CHEMBL3923240 | US9550741, III-15)
Show SMILES CCOC(=O)N[C@@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1 |r,wU:9.9,6.5,(54.47,-17.58,;52.93,-17.65,;52.1,-16.36,;50.55,-16.44,;49.86,-17.82,;49.78,-15.11,;48.24,-15.11,;47.47,-13.77,;45.93,-13.77,;45.16,-15.11,;43.62,-15.11,;42.85,-13.77,;41.31,-13.77,;40.54,-15.11,;39,-15.11,;38.23,-13.77,;39,-12.44,;40.54,-12.44,;36.69,-13.77,;35.79,-15.02,;34.32,-14.54,;34.32,-13,;33.18,-11.98,;33.5,-10.47,;34.97,-9.99,;36.11,-11.02,;35.79,-12.53,;45.93,-16.44,;47.47,-16.44,)|
Show InChI InChI=1S/C22H32N4O2S/c1-2-28-22(27)23-18-9-7-17(8-10-18)11-12-25-13-15-26(16-14-25)21-19-5-3-4-6-20(19)29-24-21/h3-6,17-18H,2,7-16H2,1H3,(H,23,27)/t17-,18+
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

US Patent
0.890n/an/an/an/an/an/a7.7n/a



Shanghai Institute of Pharmaceutical Industry

US Patent


Assay Description
1. Experimental Materials(1) 5-HT2A Cell Transfection:This experiment utilizes the plasmid vector containing the gene of the 5-HT2A receptor protein ...


US Patent US9550741 (2017)


BindingDB Entry DOI: 10.7270/Q2DN4726
More data for this
Ligand-Target Pair
5-hydroxytryptamine receptor 1A


(Homo sapiens (Human))
BDBM50207110
PNG
(CHEMBL3923240 | US9550741, III-15)
Show SMILES CCOC(=O)N[C@@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1 |r,wU:9.9,6.5,(54.47,-17.58,;52.93,-17.65,;52.1,-16.36,;50.55,-16.44,;49.86,-17.82,;49.78,-15.11,;48.24,-15.11,;47.47,-13.77,;45.93,-13.77,;45.16,-15.11,;43.62,-15.11,;42.85,-13.77,;41.31,-13.77,;40.54,-15.11,;39,-15.11,;38.23,-13.77,;39,-12.44,;40.54,-12.44,;36.69,-13.77,;35.79,-15.02,;34.32,-14.54,;34.32,-13,;33.18,-11.98,;33.5,-10.47,;34.97,-9.99,;36.11,-11.02,;35.79,-12.53,;45.93,-16.44,;47.47,-16.44,)|
Show InChI InChI=1S/C22H32N4O2S/c1-2-28-22(27)23-18-9-7-17(8-10-18)11-12-25-13-15-26(16-14-25)21-19-5-3-4-6-20(19)29-24-21/h3-6,17-18H,2,7-16H2,1H3,(H,23,27)/t17-,18+
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

US Patent
0.970n/an/an/an/an/an/a7.4n/a



Shanghai Institute of Pharmaceutical Industry

US Patent


Assay Description
1. Experimental Materials:The isotopic ligand of 5-H1A receptor [3H]0.8-OH-DPAT (purchased from PE Corporation), (+)5-hydroxytryptamine (purchased fr...


US Patent US9550741 (2017)


BindingDB Entry DOI: 10.7270/Q2DN4726
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM50207110
PNG
(CHEMBL3923240 | US9550741, III-15)
Show SMILES CCOC(=O)N[C@@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1 |r,wU:9.9,6.5,(54.47,-17.58,;52.93,-17.65,;52.1,-16.36,;50.55,-16.44,;49.86,-17.82,;49.78,-15.11,;48.24,-15.11,;47.47,-13.77,;45.93,-13.77,;45.16,-15.11,;43.62,-15.11,;42.85,-13.77,;41.31,-13.77,;40.54,-15.11,;39,-15.11,;38.23,-13.77,;39,-12.44,;40.54,-12.44,;36.69,-13.77,;35.79,-15.02,;34.32,-14.54,;34.32,-13,;33.18,-11.98,;33.5,-10.47,;34.97,-9.99,;36.11,-11.02,;35.79,-12.53,;45.93,-16.44,;47.47,-16.44,)|
Show InChI InChI=1S/C22H32N4O2S/c1-2-28-22(27)23-18-9-7-17(8-10-18)11-12-25-13-15-26(16-14-25)21-19-5-3-4-6-20(19)29-24-21/h3-6,17-18H,2,7-16H2,1H3,(H,23,27)/t17-,18+
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

US Patent
1.97n/an/an/an/an/an/a7.5n/a



Shanghai Institute of Pharmaceutical Industry

US Patent


Assay Description
1. Experimental Materials:(1) D2 receptor Cell Transfection:This experiment utilizes the plasmid vector containing the gene of D2 receptor protein fo...


US Patent US9550741 (2017)


BindingDB Entry DOI: 10.7270/Q2DN4726
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM50207110
PNG
(CHEMBL3923240 | US9550741, III-15)
Show SMILES CCOC(=O)N[C@@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1 |r,wU:9.9,6.5,(54.47,-17.58,;52.93,-17.65,;52.1,-16.36,;50.55,-16.44,;49.86,-17.82,;49.78,-15.11,;48.24,-15.11,;47.47,-13.77,;45.93,-13.77,;45.16,-15.11,;43.62,-15.11,;42.85,-13.77,;41.31,-13.77,;40.54,-15.11,;39,-15.11,;38.23,-13.77,;39,-12.44,;40.54,-12.44,;36.69,-13.77,;35.79,-15.02,;34.32,-14.54,;34.32,-13,;33.18,-11.98,;33.5,-10.47,;34.97,-9.99,;36.11,-11.02,;35.79,-12.53,;45.93,-16.44,;47.47,-16.44,)|
Show InChI InChI=1S/C22H32N4O2S/c1-2-28-22(27)23-18-9-7-17(8-10-18)11-12-25-13-15-26(16-14-25)21-19-5-3-4-6-20(19)29-24-21/h3-6,17-18H,2,7-16H2,1H3,(H,23,27)/t17-,18+
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

US Patent
1.97n/an/an/an/an/an/a7.5n/a



Shanghai Institute of Pharmaceutical Industry

US Patent


Assay Description
1. Experimental Materials:(1) D2 receptor Cell Transfection:This experiment utilizes the plasmid vector containing the gene of D2 receptor protein fo...


US Patent US9550741 (2017)


BindingDB Entry DOI: 10.7270/Q2DN4726
More data for this
Ligand-Target Pair
D(3) dopamine receptor


(Homo sapiens (Human))
BDBM50207110
PNG
(CHEMBL3923240 | US9550741, III-15)
Show SMILES CCOC(=O)N[C@@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1 |r,wU:9.9,6.5,(54.47,-17.58,;52.93,-17.65,;52.1,-16.36,;50.55,-16.44,;49.86,-17.82,;49.78,-15.11,;48.24,-15.11,;47.47,-13.77,;45.93,-13.77,;45.16,-15.11,;43.62,-15.11,;42.85,-13.77,;41.31,-13.77,;40.54,-15.11,;39,-15.11,;38.23,-13.77,;39,-12.44,;40.54,-12.44,;36.69,-13.77,;35.79,-15.02,;34.32,-14.54,;34.32,-13,;33.18,-11.98,;33.5,-10.47,;34.97,-9.99,;36.11,-11.02,;35.79,-12.53,;45.93,-16.44,;47.47,-16.44,)|
Show InChI InChI=1S/C22H32N4O2S/c1-2-28-22(27)23-18-9-7-17(8-10-18)11-12-25-13-15-26(16-14-25)21-19-5-3-4-6-20(19)29-24-21/h3-6,17-18H,2,7-16H2,1H3,(H,23,27)/t17-,18+
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
2n/an/an/an/an/an/an/an/a



Shanghai Jiao Tong University

Curated by ChEMBL


Assay Description
Displacement of [3H]methyl-spiperone from recombinant human D3 receptor expressed in CHO cell membranes after 60 mins by scintillation counting metho...


Eur J Med Chem 123: 332-353 (2016)


Article DOI: 10.1016/j.ejmech.2016.07.038
BindingDB Entry DOI: 10.7270/Q2GH9KXP
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM50207110
PNG
(CHEMBL3923240 | US9550741, III-15)
Show SMILES CCOC(=O)N[C@@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1 |r,wU:9.9,6.5,(54.47,-17.58,;52.93,-17.65,;52.1,-16.36,;50.55,-16.44,;49.86,-17.82,;49.78,-15.11,;48.24,-15.11,;47.47,-13.77,;45.93,-13.77,;45.16,-15.11,;43.62,-15.11,;42.85,-13.77,;41.31,-13.77,;40.54,-15.11,;39,-15.11,;38.23,-13.77,;39,-12.44,;40.54,-12.44,;36.69,-13.77,;35.79,-15.02,;34.32,-14.54,;34.32,-13,;33.18,-11.98,;33.5,-10.47,;34.97,-9.99,;36.11,-11.02,;35.79,-12.53,;45.93,-16.44,;47.47,-16.44,)|
Show InChI InChI=1S/C22H32N4O2S/c1-2-28-22(27)23-18-9-7-17(8-10-18)11-12-25-13-15-26(16-14-25)21-19-5-3-4-6-20(19)29-24-21/h3-6,17-18H,2,7-16H2,1H3,(H,23,27)/t17-,18+
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
4n/an/an/an/an/an/an/an/a



Shanghai Jiao Tong University

Curated by ChEMBL


Assay Description
Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method


Eur J Med Chem 123: 332-353 (2016)


Article DOI: 10.1016/j.ejmech.2016.07.038
BindingDB Entry DOI: 10.7270/Q2GH9KXP
More data for this
Ligand-Target Pair